Kane Biotech was preparing the annual financial statements and, as part of the year-end procedures, assessed the assets and prepared the following alphabetized schedule based on adjusted values at December 31, 2014:

Required 1. Record any impairment losses at December 31, 2014. Assume Kane Biotech has recorded no impairment losses in previous years. 2. Record depreciation for each asset at December 31, 2015. Assume that there was no change in the residual values or useful lives regardless of any impairment losses that might have occurred. The equipment produced 1,800 units during2